Taylor Lewis, MD
Pain Medicine · Houston, TXNPI 1083001028
Payments from drug & device makers
Across 287 payments — averaging $44.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Nevro Corp.$4K
- Boston Scientific$2K
- Stratus Medical, LLC$1K
- Globus Medical$742
- Abbott$737
- Painteq LLC$658
- plus $3K from 23 others
What the payments were for
- Consulting fees$1,25010%
- Travel & lodging$8597%
- Food & beverage$10,78584%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Nevro Corp. | 92 | $4,478 |
| Boston Scientific | 33 | $1,737 |
| Stratus Medical, LLC | 3 | $1,483 |
| Globus Medical | 34 | $742 |
| Abbott | 10 | $737 |
| Painteq LLC | 21 | $658 |
| Medtronic(2 entities) | 21 | $516 |
| Relievant Medsystems, Inc. | 8 | $415 |
| Saluda Medical Americas, Inc. | 14 | $367 |
| Stryker | 4 | $244 |
| Penumbra, Inc. | 1 | $236 |
| Cardiovascular Systems Inc. | 6 | $199 |
| AbbVie(2 entities) | 9 | $187 |
| Si-bone, Inc. | 2 | $180 |
| Cook Medical LLC | 3 | $155 |
| Pacira Therapeutics, Inc. | 7 | $132 |
| SPR Therapeutics, Inc | 2 | $81 |
| Astellas Pharma US Inc | 3 | $56 |
| Pacira Pharmaceuticals Incorporated | 1 | $53 |
| Johnson & Johnson | 3 | $52 |
| Merit Medical Systems Inc | 1 | $30 |
| Biodelivery Sciences International, Inc. | 2 | $26 |
| Bioventus LLC | 1 | $24 |
| Stimwave Technologies Incorporated | 1 | $22 |
| Averitas Pharma Inc. | 1 | $20 |
| Collegium Pharmaceutical, Inc. | 1 | $20 |
| Ferring Pharmaceuticals Inc. | 1 | $18 |
| Davol Inc. | 1 | $16 |
| Amgen | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Nimbus$1,483
- Senza Spinal Cord Stimulation System$1,018
- Senza$738
- Omnia$631
- Intracept$554
- PAINTEQ$288
- Superion Indirect Decompression System$278
- Proclaim Family of SCS IPGs$247
- Penumbra System$236
- PROCLAIM$165
- WaveWriter Alpha Prime 16$157
- Peripheral Orbital Atherectomy System$145
- iFuse Implant$127
- Evoke SCS$125
- ETERNA$121
- Mitra Clip system$117
How this compares
$12,894 in reported general payments places this provider in the 80th percentile of 583 pain medicine providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 702 | $14,375 |
| OxycontinOxycodone Hcl | 26 | $13,760 |
| Pregabalin | 343 | $9,198 |
| Gabapentin | 713 | $8,056 |
| Buprenorphine | 28 | $6,551 |
| MovantikNaloxegol Oxalate | 13 | $5,440 |
| Xtampza ErOxycodone Myristate | 13 | $4,779 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 183 | $4,042 |
| Acetaminophen-CodeineAcetaminophen With Codeine | 220 | $2,279 |
| Tizanidine Hcl | 263 | $2,160 |
| Cyclobenzaprine Hcl | 118 | $1,896 |
| Celecoxib | 60 | $1,565 |
| Fentanyl | 13 | $1,236 |
| Oxycodone Hcl | 78 | $1,177 |
| Tramadol Hcl | 265 | $1,175 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Collegium Pharmaceutical, Inc.Xtampza Er | $20 | $4,77913 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 583 pain medicine providers in Texas.
Other pain medicine in Houston
- Mitchell EngleHouston$1.5M
- Daniel PakHouston$460K
- David LeimanHouston$281K
- Grant ChenHouston$175K
- Gunjan PatelHouston$166K
- Jaideep MehtaHouston$161K
- Mayur KanjiaHouston$46K
- Baominh VinhHouston$44K
- Matthew ChungHouston$26K
- Aaron CalodneyTyler$3M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.